News

The IPO Window Is Open Again, but Only for a Certain Kind of Company

Listings have resumed after a long drought. The pipeline is dominated by profitable, infrastructure-adjacent businesses rather than growth-at-any-price stories.

New York · By Sophie Harcourt · Equities & Earnings Writer · Published

Last updated

Sophie Harcourt holds no positions in individual securities covered by Global Markets Review.

An open IPO window is not a single condition. It opens for particular profiles and stays shut for others, and the profile it favours tells you more about the market than the issuance volume does.

This year's cohort is unusually boring in the best sense: data-centre operators, payments infrastructure, industrial software, specialty insurance. What they share is demonstrable profitability at the point of listing. The pre-revenue narrative company that defined the 2021 vintage is largely absent, and where it does appear, it prices at a discount to its last private round.

Why sponsors are finally selling

Private equity and venture portfolios have been holding assets far beyond normal horizons, and the pressure to return capital has become the binding consideration. Accepting a lower valuation to achieve an exit is now a rational choice rather than a concession, which is why supply has resumed even without a valuation recovery.

The London problem

The UK continues to lose listing candidates to US exchanges, and the stated reason is consistently liquidity and index inclusion rather than regulation. Listing-rule reform addressed the complaints companies made publicly; it did not address the depth of the domestic buyer base, which is the complaint they make privately.

Free newsletter

Market Daily

One email before the US open: the overnight moves, the day's earnings, and the one number worth watching. No tips, no hype.

Frequently asked questions

Is the IPO market recovering in 2026?
Issuance has recovered materially from the 2022-24 trough, but it remains concentrated in profitable, infrastructure-adjacent issuers rather than early-stage growth companies.

Related reading